Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00750 (
PLA
)
16,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tumor necrosis factor-alpha (TNF-alpha) level, tissue-typed
plasminogen activator
(t-PA) activity and PA inhibitor (PAI) activity were determined in three groups: (1) 25 NIDDM patients with silent myocardial ischemia (SMI) or silent cerebral ischemia (SCI); (2) 18NIDDM patients without SMI or SCI; (3) 20 age-matched normal controls. Diagnosis of SMI or SCI was based on the finding of ischemic evidence by SPECT of myocardiotomograph or cerebrotomograph. All patients ECG and blood pressure were normal, and they had no history of clinical symptoms and signs of MI or CI. The result showed that the TNF-alpha level and PAI activity in the ischemia group were the highest and the t-PA activity in the ischemia group was the lowest, as compared with those in the other two groups respectively. It suggests that in NIDDM patients who have high TNF-alpha, high PAI activity, low t-PA, and even no symptoms and signs of MI or CI, anticoagulant therapy might be useful to prevent the progression of diabetic macroangiopathies.
Hua
Xi Yi Ke Da Xue Xue Bao 1997 Mar
PMID:[Changes of serum TNF-alpha level, t-PA activivty and PAI activity in patients with silent myocardial ischemia or silent cerebral ischemia]. 1068 70
The effects of bone morphogenetic protein (BMP) which can induce bone formation have been surely proved, Porous polylactic-acid blocks were prepared by a freeze-drying method. During preparation of the blocks, recombinant human bone morphogenetic protein-2(rhBMP-2) was mixed with the polylactic-acid(4 mg per block).
PLA
-rhBMP-2 was implanted in the mandibular defects of rabbit and retrieved after 2 or 4 weeks. The results showed that: with the
PLA
-rhBMP-2 blocks, new bone formation was observed in 2 weeks after implantation, and plain
PLA
blocks produced a little of new bone formation in the edges of defect even in 4 weeks after implantation. Calcium content of the retrieved
PLA
-rhBMP-2 block was statistically higher than that of plain
PLA
blocks. These results suggest that
PLA
may be effective delivery system for BMP and the
PLA
/rhBMP-2 block may potentially have usefulness as a bone graft substitute.
Hua
Xi Kou Qiang Yi Xue Za Zhi 1997 Aug
PMID:[Early observation of healing of rabbit mandibular defects with porous blocks consisting of polylactic acid and recombinant human bone morphogenetic protein-2]. 1147 95
The three-dimensional structure of an acidic phospholipase A(2) purified from the venom of Deinagkistrodon acutus (Agkistrodon acutus) was determined in a new crystal form by molecular replacement at 0.28 nm resolution with a crystallographic R factor of 21.9% (R-free=25.7%) and reasonable stereochemistry. Being similar to the previous reported crystal form, a significant conformational adaptation of segment 14-23 at the dimer interface was observed. This segment was related to the "interface recognition site" (IRS). It was found that a positively charged residue at position 34 seems to be a common feature for most of hemolytic
PLA
(2)s belonging to group II. Structural comparison between the two crystal forms showed that NaCl had significant effects on the crystal packing, thus leading to dramatic changes of the unit cell parameters. In the new crystal form, MPD (2-methyl-2, 4-pentanediol) molecules exist in the hydrophobic channel of the enzyme.
Sheng Wu
Hua
Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2002 May
PMID:Structure of an acidic phospholipase A(2) from the venom of Deinagkistrodon acutus in a new crystal form. 1201 36
Total RNA was extracted from venom glands of Ophiophagus hannah, Guangxi species. The cDNAs encoding
PLA
(2) were amplified by RT-PCR and cloned into the PUCm-T vector. The positive clones encoding two acidic
PLA
(2) (APLA(2)-1 and APLA(2)-2) were selected and bidirectionally sequenced. Their complete amino acid sequences were deduced and found to be identical to the known amino acid sequences. Their isoelectric points calculated by computer agreed with the values determined with their protein. Homology analysis indicated that the mature peptide of APLA(2)-1 had high homology with
PLA
(2) from venoms of Ophiophagus hannah, Fujian and Taiwan species, but APLA(2)-2 had lower homology. The most striking difference between APLA(2)-2 and other
PLA
(2) from Ophiophagus hannah venoms is the missing of a extra "pancreatic loop" at residues 62--66 in APLA(2)-2, and it may be related to their species evolution and biological activity.
Sheng Wu
Hua
Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2001
PMID:Cloning and Sequence Analysis of cDNAs Encoding Two Acidic PLA(2) from venom of Ophiophagus hannah(King Cobra), Guangxi Species. 1205 Jul 97
Three full-length cDNA from Lapemis hardwickii Gray, (namely
PLA
(2)-8,
PLA
(2)-9 and
PLA
(2)-384), encoding phospholipase A(2) (
PLA
(2)), were isolated and sequenced. These cDNA sequences were composed of 456 bp, 438 bp and 438 bp, encoding a signal peptide of 27 amino acids and a mature peptide of 125, 119 and 119 amino acids, respectively. The analysis results by computer indicated
PLA
(2)-8,
PLA
(2)-9and
PLA
(2)-384 has a pI of ca. 4.8, 7.8 and 8.4, respectively. Sequence analysis of amino acid and prediction of secondary structure suggested that these isoforms of
PLA
(2) belong to class I
PLA
(2) family.
PLA
(2)-8 was highly homologous (81%) to Notechis scutatus scutatus (Australian tiger snake)
PLA
(2),
PLA
(2)-9 and
PLA
(2)-384 showed fairly high sequence homology (90%) to Enhydrina schistosa (beaked sea snake)
PLA
(2), indicating that they might have similar functions. These results reflect the diversity of Lapemis hardwickii Gray
PLA
(2) genes. The successful cloning of these isoenzyme genes of sea snake
PLA
(2) may provide new information for the study on structure-function relationship of
PLA
(2) family and its possible molecular mechanism.
Sheng Wu
Hua
Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2001
PMID:Diversity of PLA(2) Genes from Sea Snake Lapemis hardwickii Gray Venom. 1205 Jul 98
In order to obtain
tissue-type plasminogen activator
(t-PA) mutant with enhanced affinity for fibrin, redesigning t-PA strategies were proposed by computer molecular designing technology, and the re-designed t-PA derivative, t-PA S165W, was expressed in CHO cells. The bio-activities and affinity for fibrin of the expression product were tested. No apparent changes were observed between t-PA S165W and wild type t-PA. Therefore, single site mutation of the t-PA could not lead to enhanced affinity for fibrin of t-PA.
Sheng Wu
Hua
Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2000
PMID:Molecular Design and Bio-activity Analysis of a t-PA Derivative (t-PA S165W). 1207 37
Plasminogen activator inhibitor type-2 (PAI-2) inhibits urokinase type
plasminogen activator
(u-PA) most specifically and high efficiently, following the mechanism of serine proteinase inhibitor (serpin) superfamily. PAI-2 plays a very important role in vivo there are, however, two conflicting views on the role of PAI-2 in cancer.
Tissue-type plasminogen activator
, vitronectin, transglutaminases, fibrin and many other molecules can interact with PAI-2. Regulation factors of PAI-2 gene expression includes many regulatory elements in the promoter region, a number of agonists and conditions of organism, etc., showing that PAI-2 gene is regulated by both positive and negative mechanisms.
Sheng Wu
Hua
Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2000
PMID:Progress in the Research of Plasminogen Activator Inhibitor Type-2. 1207 41
The cDNA encoding a new A chain of beta-bungarotoxin was cloned from Bungarus multicinctus. It encoded a 27-amino acid signal peptide and a mature protein of 120 amino acids. The mature protein had the same 13 cysteines as the other A chains and shared high homology with them. The cDNA encoding the
PLA
(2) from Naja naja atra was also cloned by the use of the same degenerate primers. The cDNAs encoding the new A chain and the
PLA
(2) were highly expressed in E. coli as soluble fusion proteins and purified by affinity chromatography. The two recombinant proteins achieved after digestion by X(a) factor showed weak and strong
PLA
(2) activity, respectively.
Sheng Wu
Hua
Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 1999
PMID:Molecular Cloning and Expression of a New A Chain of beta-Bungarotoxin. 1211 Sep 37
A novel myotoxin, designated TMPB, was purified from the venom of Trimeresurus mucrosquamatus by Sephadex G-100 superfine gel chromatography and fast protein liquid chromatography (FPLC). The N-terminal sequence of 24 amino acid residues was determined by protein sequencer. The sequence similarities between TMPB and other two phospholipase A(2) (PLA2s) previously purified from the same venom were 41.7% and 54.2%, respectively, but TMPB showed no detectable
PLA
(2) hydrolytic activity. Its molecular weight was estimated to be 16 000 by reducing SDS-PAGE and isoelectric point was determined to be 9.2 by isoelectric focusing electrophoresis. TMPB exhibited strong myotoxicity and platelet aggregation inhibiting activity, and the two activities could all be inhibited by heparin.
Sheng Wu
Hua
Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 1999
PMID:A Novel Myotoxin from the Venom of Trimeresurus mucrosquamatus. 1211 56
A cDNA encoding acidic phospholipase A(2)I(A.aAPLA(2)I)from Agkistrodon acutus was inserted into a bacterial expression vector and effectively expressed in E.coli RR1. The protein was produced as insoluble inclusion bodies. After partial purification by washing the inclusion bodies with Triton X-100, denaturing and refolding, the renatured recombinant protein was purified by FPLC column Superose(TM)12. The enzymatic acti-vity and platelet aggregation inhibiting effect of the expressed A.aAPLA(2)I is close to those of denatured-refolded native acidic
PLA
(2) from Agkistrodon halys Pallas, and has the same hemolytic activity as denatured-refolded basic phospholipase A(2) from Agkistrodon halys Pallas. The roles of various amino acid residues in the enzymatic activity and pharmacological activities of phospholipase A2 are discussed.
Sheng Wu
Hua
Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 1999
PMID:Expression and Biochemical Characterization of Acidic Phospholipase A(2)I from Agkistrodon acutus. 1211 59
1
2
Next >>